Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxycarbamide in Central Retinal Vein Occlusion
NCT02957760Phase 2Unknown
- Sponsor
- Quinze-Vingts Hospital
- Start
- Dec 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in central retinal vein occlusion (CRVO), sponsored by Quinze-Vingts Hospital. Status: unknown.
02
Drugs
hydroxyurea
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on NCT02957760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957760.